Join our Live Stream
The importance of CRP Point of Care testing in
respiratory infections and in the fight against
COVID-19 and Antimicrobial
4th September | 15:30 — 16:45 CET
Prof. Nicholas Francis
Prof. Ivan Gentile
Severity assessment and outcome prediction in the COVID-19 patients
Dr. Carl Llor
The emergence of multi-resistance associated with the overuse of antibiotics during COVID-19 pandemic
Prof. Dag Berild
Antimicrobial stewardship in the time of COVID-19 is vital — AMR still persists and could be height
Dr. Aggy York
Panel Discussion: CRP and Point of Care testing — knowledge sharing from across Europe
Join a panel of experts from across Europe for this compelling webinar presenting a view from the front line in Europe.
90% of respiratory tract infections (RTIs) are viral and therefore antibiotics have no clinical benefit. And yet RTIs are one of the most common reasons for unnecessary antibiotic prescribing. 
- Despite the viral origin of COVID-19, a standard reflex by physicians is to start treatment with antibiotics since cough, fever and radiologic infiltrates are hallmarks of bacterial community-acquired pneumonia, which requires antibiotic treatment. 
- The detection of CRP is of certain value to distinguish whether there is a bacterial infection in the lung. 
- CRP may reflect disease severity and may be an independent predictor of adverse outcomes in COVID-19 patients.     
- Antibiotics should be reserved for the patients with the most severe presentations. 
- Avoid blind or inappropriate use of antibacterial drugs, especially the combination of broad-spectrum antibacterial drugs. 
- There are many reasons why European countries launch Antibiotic Stewardship Programs (ASPs), and in the context of COVID-19, an ASP is needed now more than ever.
Professional Blended Learning Continuum
- MyPOCAcademy is an interactive educational resource providing information on the rationale for Point of Care Testing testing and its value, across a number of medical specialities.
- The courses will allow you to enhance your knowledge and skills at your own pace.
- CME-accredited materials and webinars will be available shortly
Assess Your Understanding
- Within each course are test questions that allow you to test your knowledge.
- Interactive patient case studies enable you to view the benefits of Point of Care Testing in real-life clinical scenarios
Convenient Access to Latest POC Information
- MyPOCAcademy is your go-to resource for the latest information related to Point of Care Testing.
- Learning can be accessed at your convenience with the click of a button.
- ↑ CDC. Interim Clinical Guidance for Management of Patients with Confirmed Coronavirus Disease (COVID-19). April 3, 2020. — https://www.cdc.gov/coronavirus/2019-ncov/hcp/clinical-guidancemanagement-patients.html#lab-findings
- ↑ Luo X, et al. medRxiv. Published online 2020. — https://doi.org/10.1101/2020.03.21.20040360
- ↑ Tan C, et al. ORCID iD: 0000-0002-2522-4524. —
- ↑ Wang L. Médecine et maladies infectieuses. 2020. — https://doi.org/10.1016/j.medmal.2020.03.007
- ↑ Li H, et al. Journal of Infection. Published online 2020. — https://doi.org/10.1016/j.jinf.2020.03.035
- ↑ Huttner B, et al. COVID-19: Don’t neglect antimicrobial stewardship: principles! Clinical Microbiology and Infection. 2020. — https://doi.org/10.1016/j.cmi.2020.04.024
- ↑ Guan W, et al. Clinical Characteristics of Coronavirus Disease 2019 in China. N Engl J Med. 2020;382:1708-20. doi:10.1056/NEJMoa2002032 —
- ↑ Rawson T, et al. Bacterial and fungal co-infection in individuals with coronavirus: A rapid review to support COVID-19 antimicrobial prescribing. Clin Infect Dis. 2020;2:ciaa530. doi:10.1093/cid/ciaa530.32358954 —
- ↑ Jin YH, et al. A rapid advice guideline for the diagnosis and treatment of 2019 novel coronavirus (2019-nCoV) infected pneumonia (standard version). Military Medical Research. 2020;7:4. — https://doi.org/10.1186/s40779-020-0233-6
- ↑ Aabenhus R, et al. Cochrane Database of Systematic Reviews. 2014;11. Art. No.: CD010130. —